Literature DB >> 7067730

High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline.

R Raisman, M Sette, C Pimoule, M Briley, S Z Langer.   

Abstract

The specific binding of [3H]desipramine to various brain regions and peripheral tissues of the rat was of high affinity, rapid and reversible. It was inhibited with high affinity only by tricyclic antidepressants and noradrenaline uptake blockers. There was a highly significant correlation between the potencies of a series of drugs for the inhibition of [3H]desipramine binding and for the inhibition of noradrenaline uptake. Substrates for the noradrenaline uptake system however inhibited the binding of [3H]desipramine only at very high concentrations. Postganglionic sympathetic denervation of the submaxillary gland and the heart both resulted in a pronounced decrease in [3H]desipramine binding sites, which paralleled the reduction in endogenous noradrenaline levels. High-affinity [3H]desipramine binding sites thus appear to be localised on noradrenergic nerve endings and are probably closely associated with the neuronal uptake system for noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7067730     DOI: 10.1016/0014-2999(82)90036-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Characterization of the [3H]-desipramine binding site of the bovine adrenomedullary plasma membrane.

Authors:  J Michael-Hepp; B Blum; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

2.  Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells.

Authors:  S Streich; M Brüss; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

3.  Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.

Authors:  Liting Deng; Wan-Hung Lee; Zhili Xu; Alexandros Makriyannis; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2016-10-20       Impact factor: 7.658

4.  Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier.

Authors:  E Schömig; M Körber; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

5.  Proceedings of the British Pharmacological Society. Cardiff, 10th-12th April, 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

6.  Inhibitory synaptic potentials recorded from mammalian neurones prolonged by blockade of noradrenaline uptake.

Authors:  A Surprenant; J T Williams
Journal:  J Physiol       Date:  1987-01       Impact factor: 5.182

7.  Interactions of amineptine with the neuronal dopamine uptake system: neurochemical in vitro and in vivo studies.

Authors:  J J Bonnet; A Chagraoui; P Protais; J Costentin
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

8.  Preferential location of N-methyl-D-aspartate (NMDA) receptors on postsynaptic membranes and on non-noradrenergic nerve terminals of the rat brain cortex.

Authors:  K Fink; M Blohm; G Molderings; H Bönisch; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

9.  Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake.

Authors:  J Sallés; A Badia
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

10.  Plasma-soluble marker for intraorgan regional flows.

Authors:  S E Little; J B Bassingthwaighte
Journal:  Am J Physiol       Date:  1983-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.